Scottish startup Novosound has expanded its healthcare and wireless wearable ultrasound operations in the US. Industry sources added that the firm has recently entered a wearable ultrasound collaboration with one of America’s leading cardiovascular surgeons, Todd K. Rosengart, Vice President and DeBakey-Bard Chair of Surgery at Baylor College of Medicine, based within the Texas Medical Centre in Houston.
Novosound CEO, Dr Dave Hughes, stated: “We’re making remarkable progress in the US, venturing into varied sectors such as healthcare, wearables with several clients in the West Coast tech scene, renewables and energy, including an introductory visit to Axiom Space, which closely follows their exciting partnership announcement with the UK Space Agency.”
Dave Hughes added: “We’re seeing that our R&D partnerships are frequently translating to commercial agreements, and we expect to announce a number of these in 2024.”
Hughes continued: “Novosound is growing rapidly across our three main sectors – medical, wearables, and industrial monitoring, in North America. On the financials, this equates to us doubling revenue for the fourth year in a row, while adding expertise to the team. Overall, we’re demonstrating that we’re at the forefront of ultrasound sensor technology, and our clients are helping us achieve our vision, which we describe as ‘Ultrasound. Integrated. Everywhere.”
Additionally, the previously announced medical imaging collaborations with Nasdaq-listed PAVmed Inc. and dental company dSound continue to progress through significant developmental milestones.
Kilo Health Experts Reveal Health Tech Trends that Are Changing the World
Envision Healthcare announces two major appointments
Acadia Healthcare appoints Dr. Patrice A. Harris as Independent Director
